Association of low serum aluminum level with mortality in hemodialysis patients

Ching-Wei Hsu,1–3 Cheng-Hao Weng,1–3 Cheng-Chia Lee,1–3 Dan-Tzu Lin-Tan,1–3 Kuan-Hsing Chen,1–3 Tzung-Hai Yen,1–3 Wen-Hung Huang1–3 1Department of Nephrology, Division of Clinical Toxicology, Chang Gung Memorial Hospital, Taipei,...

Full description

Bibliographic Details
Main Authors: Hsu CW, Weng CH, Lee CC, Lin-Tan DT, Chen KH, Yen TH, Huang WH
Format: Article
Language:English
Published: Dove Medical Press 2016-09-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Online Access:https://www.dovepress.com/association-of-low-serum-aluminum-level-with-mortality-in-hemodialysis-peer-reviewed-article-TCRM
_version_ 1819145300276674560
author Hsu CW
Weng CH
Lee CC
Lin-Tan DT
Chen KH
Yen TH
Huang WH
author_facet Hsu CW
Weng CH
Lee CC
Lin-Tan DT
Chen KH
Yen TH
Huang WH
author_sort Hsu CW
collection DOAJ
description Ching-Wei Hsu,1–3 Cheng-Hao Weng,1–3 Cheng-Chia Lee,1–3 Dan-Tzu Lin-Tan,1–3 Kuan-Hsing Chen,1–3 Tzung-Hai Yen,1–3 Wen-Hung Huang1–3 1Department of Nephrology, Division of Clinical Toxicology, Chang Gung Memorial Hospital, Taipei, Taiwan, Republic of China; 2Department of Nephrology, Division of Clinical Toxicology, Linkou Medical Center, Taoyuan, Taiwan, Republic of China; 3Department of Medicine, Chang Gung University College of Medicine, Taoyuan, Taiwan, Republic of China Background: The National Kidney Foundation–Kidney Disease Outcomes Quality Initiative recommends that the serum aluminum level (SAL) should be below 20 µg/L for patients with maintenance hemodialysis (MHD). However, serum aluminum may have toxic effects on MHD patients even when it is in the apparently acceptable range (below 20 µg/L).Methods: The Medical Ethics Committee approved this study. Initially, 954 MHD patients in dialysis centers were recruited. A total of 901 patients met the inclusion criteria and were followed-up for 1 year. Patients were stratified by SAL into four equal-sized groups: first quartile (<6 µg/L), second quartile (6–9 µg/L), third quartile (9–13 µg/L), and fourth quartile (>13 µg/L). Demographic, biochemical, and dialysis-related data were obtained for analyses. A linear regression model was applied to identify factors associated with SAL. Cox proportional hazard model was used to determine the significance of variables in prediction of mortality.Results: Only 9.3% of MHD patients had SALs of 20 µg/L or more. At the end of the follow-up, 54 patients (6%) died, and the main cause of death was cardiovascular disease. Kaplan–Meier survival analysis showed that patients in the fourth SAL quartile had higher mortality than those in the first SAL quartile (log rank test, χ2=13.47, P=0.004). Using the first quartile as reference, Cox multivariate analysis indicated that patients in the third quartile (hazard ratio =1.31, 95% confidence interval =1.12–1.53, P=0.038) and the fourth quartile (hazard ratio =3.19, 95% confidence interval =1.08–8.62, P=0.048) had increased risk of all-cause mortality.Conclusion: This study demonstrates that SAL, even when in an apparently acceptable range (below 20 µg/L), is associated with increased mortality in MHD patients. The findings suggest that avoiding exposure of aluminum as much as possible is warranted for MHD patients. Keywords: aluminum, mortality, hemodialysis
first_indexed 2024-12-22T12:55:50Z
format Article
id doaj.art-03f4d6eafdbd447491058193b643bed0
institution Directory Open Access Journal
issn 1178-203X
language English
last_indexed 2024-12-22T12:55:50Z
publishDate 2016-09-01
publisher Dove Medical Press
record_format Article
series Therapeutics and Clinical Risk Management
spelling doaj.art-03f4d6eafdbd447491058193b643bed02022-12-21T18:25:07ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2016-09-01Volume 121417142428918Association of low serum aluminum level with mortality in hemodialysis patientsHsu CWWeng CHLee CCLin-Tan DTChen KHYen THHuang WHChing-Wei Hsu,1–3 Cheng-Hao Weng,1–3 Cheng-Chia Lee,1–3 Dan-Tzu Lin-Tan,1–3 Kuan-Hsing Chen,1–3 Tzung-Hai Yen,1–3 Wen-Hung Huang1–3 1Department of Nephrology, Division of Clinical Toxicology, Chang Gung Memorial Hospital, Taipei, Taiwan, Republic of China; 2Department of Nephrology, Division of Clinical Toxicology, Linkou Medical Center, Taoyuan, Taiwan, Republic of China; 3Department of Medicine, Chang Gung University College of Medicine, Taoyuan, Taiwan, Republic of China Background: The National Kidney Foundation–Kidney Disease Outcomes Quality Initiative recommends that the serum aluminum level (SAL) should be below 20 µg/L for patients with maintenance hemodialysis (MHD). However, serum aluminum may have toxic effects on MHD patients even when it is in the apparently acceptable range (below 20 µg/L).Methods: The Medical Ethics Committee approved this study. Initially, 954 MHD patients in dialysis centers were recruited. A total of 901 patients met the inclusion criteria and were followed-up for 1 year. Patients were stratified by SAL into four equal-sized groups: first quartile (<6 µg/L), second quartile (6–9 µg/L), third quartile (9–13 µg/L), and fourth quartile (>13 µg/L). Demographic, biochemical, and dialysis-related data were obtained for analyses. A linear regression model was applied to identify factors associated with SAL. Cox proportional hazard model was used to determine the significance of variables in prediction of mortality.Results: Only 9.3% of MHD patients had SALs of 20 µg/L or more. At the end of the follow-up, 54 patients (6%) died, and the main cause of death was cardiovascular disease. Kaplan–Meier survival analysis showed that patients in the fourth SAL quartile had higher mortality than those in the first SAL quartile (log rank test, χ2=13.47, P=0.004). Using the first quartile as reference, Cox multivariate analysis indicated that patients in the third quartile (hazard ratio =1.31, 95% confidence interval =1.12–1.53, P=0.038) and the fourth quartile (hazard ratio =3.19, 95% confidence interval =1.08–8.62, P=0.048) had increased risk of all-cause mortality.Conclusion: This study demonstrates that SAL, even when in an apparently acceptable range (below 20 µg/L), is associated with increased mortality in MHD patients. The findings suggest that avoiding exposure of aluminum as much as possible is warranted for MHD patients. Keywords: aluminum, mortality, hemodialysishttps://www.dovepress.com/association-of-low-serum-aluminum-level-with-mortality-in-hemodialysis-peer-reviewed-article-TCRMaluminummortalityhemodialysis
spellingShingle Hsu CW
Weng CH
Lee CC
Lin-Tan DT
Chen KH
Yen TH
Huang WH
Association of low serum aluminum level with mortality in hemodialysis patients
Therapeutics and Clinical Risk Management
aluminum
mortality
hemodialysis
title Association of low serum aluminum level with mortality in hemodialysis patients
title_full Association of low serum aluminum level with mortality in hemodialysis patients
title_fullStr Association of low serum aluminum level with mortality in hemodialysis patients
title_full_unstemmed Association of low serum aluminum level with mortality in hemodialysis patients
title_short Association of low serum aluminum level with mortality in hemodialysis patients
title_sort association of low serum aluminum level with mortality in hemodialysis patients
topic aluminum
mortality
hemodialysis
url https://www.dovepress.com/association-of-low-serum-aluminum-level-with-mortality-in-hemodialysis-peer-reviewed-article-TCRM
work_keys_str_mv AT hsucw associationoflowserumaluminumlevelwithmortalityinhemodialysispatients
AT wengch associationoflowserumaluminumlevelwithmortalityinhemodialysispatients
AT leecc associationoflowserumaluminumlevelwithmortalityinhemodialysispatients
AT lintandt associationoflowserumaluminumlevelwithmortalityinhemodialysispatients
AT chenkh associationoflowserumaluminumlevelwithmortalityinhemodialysispatients
AT yenth associationoflowserumaluminumlevelwithmortalityinhemodialysispatients
AT huangwh associationoflowserumaluminumlevelwithmortalityinhemodialysispatients